FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:DHRS12-ATP7B

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: DHRS12-ATP7B
FusionPDB ID: 22561
FusionGDB2.0 ID: 22561
HgeneTgene
Gene symbol

DHRS12

ATP7B

Gene ID

79758

540

Gene namedehydrogenase/reductase 12ATPase copper transporting beta
SynonymsSDR40C1PWD|WC1|WD|WND
Cytomap

13q14.3

13q14.3

Type of geneprotein-codingprotein-coding
Descriptiondehydrogenase/reductase SDR family member 12dehydrogenase/reductase (SDR family) member 12short-chain dehydrogenase/reductase family 40C member 1copper-transporting ATPase 2ATPase, Cu(2+)- transporting, beta polypeptideATPase, Cu++ transporting, beta polypeptideWilson disease-associated proteincopper pump 2copper-transporting protein ATP7B
Modification date2020031320200329
UniProtAcc

A0PJE2

Main function of 5'-partner protein: FUNCTION: Putative oxidoreductase. {ECO:0000250}.

P35670

Main function of 5'-partner protein: FUNCTION: Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload. {ECO:0000269|PubMed:18203200, ECO:0000269|PubMed:22240481, ECO:0000269|PubMed:24706876, ECO:0000269|PubMed:26004889}.
Ensembl transtripts involved in fusion geneENST idsENST00000218981, ENST00000280056, 
ENST00000444610, ENST00000490949, 
ENST00000482841, ENST00000542656, 
ENST00000417240, ENST00000242839, 
ENST00000344297, ENST00000400366, 
ENST00000400370, ENST00000418097, 
ENST00000448424, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 7 X 4=1685 X 6 X 3=90
# samples 75
** MAII scorelog2(7/168*10)=-1.26303440583379
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/90*10)=-0.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: DHRS12 [Title/Abstract] AND ATP7B [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: DHRS12 [Title/Abstract] AND ATP7B [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DHRS12(52371962)-ATP7B(52518427), # samples:1
DHRS12(52373670)-ATP7B(52516690), # samples:1
Anticipated loss of major functional domain due to fusion event.DHRS12-ATP7B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DHRS12-ATP7B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
DHRS12-ATP7B seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneATP7B

GO:0006825

copper ion transport

26004889

TgeneATP7B

GO:0015677

copper ion import

16472602

TgeneATP7B

GO:0046688

response to copper ion

15269005|16472602|16939419

TgeneATP7B

GO:0051208

sequestering of calcium ion

16472602



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:52371962/chr13:52518427)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across DHRS12 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ATP7B (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000444610DHRS12chr1352371962-ENST00000242839ATP7Bchr1352518427-3708287141624536
ENST00000444610DHRS12chr1352371962-ENST00000400366ATP7Bchr1352518427-3707287141624536
ENST00000444610DHRS12chr1352371962-ENST00000344297ATP7Bchr1352518427-3707287141624536
ENST00000444610DHRS12chr1352371962-ENST00000400370ATP7Bchr1352518427-1695287141624536
ENST00000444610DHRS12chr1352371962-ENST00000448424ATP7Bchr1352518427-1695287141624536
ENST00000444610DHRS12chr1352371962-ENST00000418097ATP7Bchr1352518427-1688287141624536
ENST00000218981DHRS12chr1352373670-ENST00000242839ATP7Bchr1352516690-34762381121392426
ENST00000218981DHRS12chr1352373670-ENST00000400366ATP7Bchr1352516690-34752381121392426
ENST00000218981DHRS12chr1352373670-ENST00000344297ATP7Bchr1352516690-34752381121392426
ENST00000218981DHRS12chr1352373670-ENST00000400370ATP7Bchr1352516690-14632381121392426
ENST00000218981DHRS12chr1352373670-ENST00000448424ATP7Bchr1352516690-14632381121392426
ENST00000218981DHRS12chr1352373670-ENST00000418097ATP7Bchr1352516690-14562381121392426
ENST00000218981DHRS12chr1352373670-ENST00000417240ATP7Bchr1352516690-15452381121392426
ENST00000280056DHRS12chr1352373670-ENST00000242839ATP7Bchr1352516690-3417179531333426
ENST00000280056DHRS12chr1352373670-ENST00000400366ATP7Bchr1352516690-3416179531333426
ENST00000280056DHRS12chr1352373670-ENST00000344297ATP7Bchr1352516690-3416179531333426
ENST00000280056DHRS12chr1352373670-ENST00000400370ATP7Bchr1352516690-1404179531333426
ENST00000280056DHRS12chr1352373670-ENST00000448424ATP7Bchr1352516690-1404179531333426
ENST00000280056DHRS12chr1352373670-ENST00000418097ATP7Bchr1352516690-1397179531333426
ENST00000280056DHRS12chr1352373670-ENST00000417240ATP7Bchr1352516690-1486179531333426

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000444610ENST00000242839DHRS12chr1352371962-ATP7Bchr1352518427-0.0023958940.9976042
ENST00000444610ENST00000400366DHRS12chr1352371962-ATP7Bchr1352518427-0.002388050.997612
ENST00000444610ENST00000344297DHRS12chr1352371962-ATP7Bchr1352518427-0.002388050.997612
ENST00000444610ENST00000400370DHRS12chr1352371962-ATP7Bchr1352518427-0.0058583580.99414164
ENST00000444610ENST00000448424DHRS12chr1352371962-ATP7Bchr1352518427-0.0058583580.99414164
ENST00000444610ENST00000418097DHRS12chr1352371962-ATP7Bchr1352518427-0.0057079770.994292
ENST00000218981ENST00000242839DHRS12chr1352373670-ATP7Bchr1352516690-0.0017341910.9982658
ENST00000218981ENST00000400366DHRS12chr1352373670-ATP7Bchr1352516690-0.0017216040.9982784
ENST00000218981ENST00000344297DHRS12chr1352373670-ATP7Bchr1352516690-0.0017216040.9982784
ENST00000218981ENST00000400370DHRS12chr1352373670-ATP7Bchr1352516690-0.0034077450.9965922
ENST00000218981ENST00000448424DHRS12chr1352373670-ATP7Bchr1352516690-0.0034077450.9965922
ENST00000218981ENST00000418097DHRS12chr1352373670-ATP7Bchr1352516690-0.003409790.99659026
ENST00000218981ENST00000417240DHRS12chr1352373670-ATP7Bchr1352516690-0.0033139820.99668604
ENST00000280056ENST00000242839DHRS12chr1352373670-ATP7Bchr1352516690-0.0017725870.9982274
ENST00000280056ENST00000400366DHRS12chr1352373670-ATP7Bchr1352516690-0.0017604180.9982395
ENST00000280056ENST00000344297DHRS12chr1352373670-ATP7Bchr1352516690-0.0017604180.9982395
ENST00000280056ENST00000400370DHRS12chr1352373670-ATP7Bchr1352516690-0.0030969810.996903
ENST00000280056ENST00000448424DHRS12chr1352373670-ATP7Bchr1352516690-0.0030969810.996903
ENST00000280056ENST00000418097DHRS12chr1352373670-ATP7Bchr1352516690-0.0031005590.9968995
ENST00000280056ENST00000417240DHRS12chr1352373670-ATP7Bchr1352516690-0.0029361740.9970638

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for DHRS12-ATP7B

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
DHRS12chr1352371962ATP7Bchr135251842728790EDARGEIIRESGNQIKTVMFDKTGTI
DHRS12chr1352373670ATP7Bchr135251669017934FWSLEETAALAKQLPLKSPSEELGTE
DHRS12chr1352373670ATP7Bchr135251669023834FWSLEETAALAKQLPLKSPSEELGTE

Top

Potential FusionNeoAntigen Information of DHRS12-ATP7B in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DHRS12-ATP7B_52371962_52518427.msa
DHRS12-ATP7B_52373670_52516690.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B45:01RESGNQIKT0.91550.5714817
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B41:01RESGNQIKT0.27560.5369817
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B50:01RESGNQIKT0.10310.5229817
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B41:01RESGNQIKTV0.77720.6148818
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B39:13RESGNQIKTVM0.99260.8954819
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B40:06RESGNQIKT0.97250.5215817
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B39:08RESGNQIKTVM0.99540.7175819
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B18:08NQIKTVMF0.91030.82151220
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B18:04NQIKTVMF0.89460.94541220
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-C16:01SGNQIKTVM0.86080.96631019
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B07:13SGNQIKTVM0.59630.731019
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B50:05RESGNQIKT0.10310.5229817
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B50:04RESGNQIKT0.10310.5229817
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B40:04GEIIRESGNQI0.99910.6448415
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B40:04RESGNQIKTVM0.9990.8037819
DHRS12-ATP7Bchr1352371962chr1352518427287HLA-B41:03GEIIRESGNQI0.9120.6107415
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-A26:15ETAALAKQL0.99760.5068514
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-A26:14ETAALAKQL0.99760.5068514
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B08:01AALAKQLPL0.99740.8228716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-A30:08ALAKQLPLK0.9850.6913817
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B44:03EETAALAKQL0.98740.9325414
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:19AALAKQLPL0.99970.996716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:07AALAKQLPL0.99970.9898716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C15:06AALAKQLPL0.99960.967716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:08AALAKQLPL0.99960.9531716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-A26:01ETAALAKQL0.99760.5068514
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C08:04AALAKQLPL0.98770.9921716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C08:13AALAKQLPL0.98770.9921716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B44:10EETAALAKQL0.96410.5183414
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C01:17QLPLKSPSEEL0.99540.97331223
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C16:01TAALAKQL0.98780.9802614
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:03AALAKQLPL0.99970.9948716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:04AALAKQLPL0.99970.9948716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C15:02AALAKQLPL0.99950.9699716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:17AALAKQLPL0.99940.9857716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C15:05AALAKQLPL0.99940.9808716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:05AALAKQLPL0.99940.9673716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-A25:01ETAALAKQL0.99880.8338514
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B08:18AALAKQLPL0.99740.8228716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C03:06AALAKQLPL0.99370.9953716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C16:02AALAKQLPL0.99290.9962716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C16:01AALAKQLPL0.98520.9903716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-A30:01ALAKQLPLK0.98210.8493817
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B08:12AALAKQLPL0.96030.9076716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B35:13AALAKQLPL0.91050.9396716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C17:01AALAKQLPL0.85130.9781716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B07:13AALAKQLPL0.82580.8572716
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B44:13EETAALAKQL0.98740.9325414
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B44:26EETAALAKQL0.98740.9325414
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-B44:07EETAALAKQL0.98740.9325414
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C01:03QLPLKSPSEEL0.99870.9611223
DHRS12-ATP7Bchr1352373670chr1352516690238HLA-C01:02QLPLKSPSEEL0.99780.97321223

Top

Potential FusionNeoAntigen Information of DHRS12-ATP7B in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DHRS12-ATP7B_52371962_52518427.msa
DHRS12-ATP7B_52373670_52516690.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0101RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0101ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0102RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0102ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0102DARGEIIRESGNQIK116
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0102GEIIRESGNQIKTVM419
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0105RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0105ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0107RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0107ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0109RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0109ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0111RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0111ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0111DARGEIIRESGNQIK116
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0113RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0113ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0115RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0115ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0117RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0117ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0119RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0119ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0121RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0121ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0123RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0123ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0125RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0125ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0127RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0127ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0129RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0129ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0131RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0131ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0338RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-0704RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1331RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1331ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1448RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1448ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1448DARGEIIRESGNQIK116
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1449RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1449ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1507RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1525RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1525ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1525DARGEIIRESGNQIK116
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1525GEIIRESGNQIKTVM419
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1534RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1534ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1537RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1548RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1615RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB1-1615ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0109RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0109ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0201RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0201ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0204RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0204ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0209RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0209ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0221RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0221ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0224RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0224ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0301RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0301ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0301DARGEIIRESGNQIK116
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0303RGEIIRESGNQIKTV318
DHRS12-ATP7Bchr1352371962chr1352518427287DRB3-0303ARGEIIRESGNQIKT217
DHRS12-ATP7Bchr1352373670chr1352516690238DRB4-0104TAALAKQLPLKSPSE621

Top

Fusion breakpoint peptide structures of DHRS12-ATP7B

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3739IIRESGNQIKTVMFDHRS12ATP7Bchr1352371962chr1352518427287
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
9216TAALAKQLPLKSPSDHRS12ATP7Bchr1352373670chr1352516690238

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of DHRS12-ATP7B

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3739IIRESGNQIKTVMF-7.15543-7.26883
HLA-B14:023BVN3739IIRESGNQIKTVMF-4.77435-5.80965
HLA-B52:013W393739IIRESGNQIKTVMF-6.80875-6.92215
HLA-B52:013W393739IIRESGNQIKTVMF-4.20386-5.23916
HLA-A11:014UQ23739IIRESGNQIKTVMF-7.5194-8.5547
HLA-A11:014UQ23739IIRESGNQIKTVMF-6.9601-7.0735
HLA-A24:025HGA3739IIRESGNQIKTVMF-7.52403-7.63743
HLA-A24:025HGA3739IIRESGNQIKTVMF-5.82433-6.85963
HLA-B27:056PYJ3739IIRESGNQIKTVMF-3.28285-4.31815
HLA-B44:053DX83739IIRESGNQIKTVMF-5.91172-6.94702
HLA-B44:053DX83739IIRESGNQIKTVMF-4.24346-4.35686
HLA-B14:023BVN9216TAALAKQLPLKSPS-6.35143-7.38673
HLA-B14:023BVN9216TAALAKQLPLKSPS-5.20162-5.31502
HLA-B52:013W399216TAALAKQLPLKSPS-6.03049-6.14389
HLA-B52:013W399216TAALAKQLPLKSPS-5.12323-6.15853
HLA-A24:025HGA9216TAALAKQLPLKSPS-9.81198-9.92538
HLA-A24:025HGA9216TAALAKQLPLKSPS-7.16433-8.19963
HLA-B44:053DX89216TAALAKQLPLKSPS-6.46131-6.57471
HLA-B44:053DX89216TAALAKQLPLKSPS-3.08576-4.12106
HLA-A02:016TDR9216TAALAKQLPLKSPS-5.03933-5.15273

Top

Vaccine Design for the FusionNeoAntigens of DHRS12-ATP7B

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
DHRS12-ATP7Bchr1352371962chr13525184271019SGNQIKTVMGGTAACCAGATAAAGACTGTGATGTTT
DHRS12-ATP7Bchr1352371962chr13525184271220NQIKTVMFCAGATAAAGACTGTGATGTTTGAC
DHRS12-ATP7Bchr1352371962chr1352518427415GEIIRESGNQIGAGATCATCCGGGAGAGCGGTAACCAGATAAAG
DHRS12-ATP7Bchr1352371962chr1352518427817RESGNQIKTGAGAGCGGTAACCAGATAAAGACTGTG
DHRS12-ATP7Bchr1352371962chr1352518427818RESGNQIKTVGAGAGCGGTAACCAGATAAAGACTGTGATG
DHRS12-ATP7Bchr1352371962chr1352518427819RESGNQIKTVMGAGAGCGGTAACCAGATAAAGACTGTGATGTTT
DHRS12-ATP7Bchr1352373670chr13525166901223QLPLKSPSEELGAGGAACTTGGAACAGAGACCTTGGGATACTGC
DHRS12-ATP7Bchr1352373670chr1352516690414EETAALAKQLCAACTGCCCTTGAAATCGCCAAGCGAGGAA
DHRS12-ATP7Bchr1352373670chr1352516690514ETAALAKQLCTGCCCTTGAAATCGCCAAGCGAGGAA
DHRS12-ATP7Bchr1352373670chr1352516690614TAALAKQLCCCTTGAAATCGCCAAGCGAGGAA
DHRS12-ATP7Bchr1352373670chr1352516690716AALAKQLPLTTGAAATCGCCAAGCGAGGAACTTGGA
DHRS12-ATP7Bchr1352373670chr1352516690817ALAKQLPLKAAATCGCCAAGCGAGGAACTTGGAACA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
DHRS12-ATP7Bchr1352371962chr1352518427116DARGEIIRESGNQIKGCCAGGGGTGAGATCATCCGGGAGAGCGGTAACCAGATAAAGACT
DHRS12-ATP7Bchr1352371962chr1352518427217ARGEIIRESGNQIKTAGGGGTGAGATCATCCGGGAGAGCGGTAACCAGATAAAGACTGTG
DHRS12-ATP7Bchr1352371962chr1352518427318RGEIIRESGNQIKTVGGTGAGATCATCCGGGAGAGCGGTAACCAGATAAAGACTGTGATG
DHRS12-ATP7Bchr1352371962chr1352518427419GEIIRESGNQIKTVMGAGATCATCCGGGAGAGCGGTAACCAGATAAAGACTGTGATGTTT
DHRS12-ATP7Bchr1352373670chr1352516690621TAALAKQLPLKSPSECCCTTGAAATCGCCAAGCGAGGAACTTGGAACAGAGACCTTGGGA

Top

Information of the samples that have these potential fusion neoantigens of DHRS12-ATP7B

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADDHRS12-ATP7Bchr1352373670ENST00000218981chr1352516690ENST00000242839TCGA-BR-A4QI-01A
STADDHRS12-ATP7Bchr1352371962ENST00000444610chr1352518427ENST00000242839TCGA-BR-A4QI-01A

Top

Potential target of CAR-T therapy development for DHRS12-ATP7B

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneATP7Bchr13:52371962chr13:52518427ENST0000024283912211323_134001466.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST0000024283912211352_137101466.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST000003442978171323_134001259.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST000003442978171352_137101259.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST00000344297817920_94201259.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST00000344297817973_99401259.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST0000040036613221323_134001355.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST0000040036613221352_137101355.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST000004003661322920_94201355.0TransmembraneHelical
TgeneATP7Bchr13:52371962chr13:52518427ENST000004003661322973_99401355.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST0000024283913211323_134001466.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST0000024283913211352_137101466.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST000003442979171323_134001259.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST000003442979171352_137101259.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST00000344297917920_94201259.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST00000344297917973_99401259.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST0000040036614221323_134001355.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST0000040036614221352_137101355.0TransmembraneHelical
TgeneATP7Bchr13:52373670chr13:52516690ENST000004003661422973_99401355.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to DHRS12-ATP7B

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to DHRS12-ATP7B

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource